Ligasan, Sarahme S.

HRN: 23-82-06  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/29/2023
CEFUROXIME 750MG (VIAL)
09/29/2023
10/06/2023
IV
330mg
Q8H
AGE
Waiting Final Action 
10/01/2023
CEFTRIAXONE 1G (VIAL)
10/01/2023
10/08/2023
IV
400 Mg
Every 12 Hours
AGE With Severe Dehydration
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: